Naomi Falk, MD
Retina Specialist · Slingerlands, NYNPI 1649271859
Payments from drug & device makers
Across 102 payments — averaging $4271.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$426K
- Eyepoint US, Inc.$6K
- Janssen Research & Development, LLC$4K
- Amgen$85
- AbbVie$76
- Harrow Eye, LLC$45
- plus $76 from 3 others
What the payments were for
- Food & beverage$26293%
- Gifts$197%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 85 | $425,948 |
| Eyepoint US, Inc. | 3 | $5,764 |
| Janssen Research & Development, LLC | 1 | $3,705 |
| Amgen | 4 | $85 |
| AbbVie | 3 | $76 |
| Harrow Eye, LLC | 2 | $45 |
| Alimera Sciences, Inc. | 2 | $34 |
| Apellis Pharmaceuticals, Inc. | 1 | $22 |
| Carl Zeiss Meditec AG | 1 | $19 |
How this compares
$435,699 in reported general payments places this provider in the 95th percentile of 99 retina specialist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 252 | $47,628 |
| ProlensaBromfenac Sodium | 31 | $13,124 |
| Prednisolone Acetate | 179 | $11,425 |
| Difluprednate | 52 | $5,827 |
| IlevroNepafenac | 12 | $4,859 |
| Ketorolac Tromethamine | 96 | $3,127 |
| Brimonidine Tartrate | 54 | $2,997 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 66 | $1,533 |
| Atropine Sulfate | 19 | $1,255 |
| Acetazolamide ErAcetazolamide | 19 | $1,019 |
| Dorzolamide Hcl | 51 | $895 |
| ValacyclovirValacyclovir Hcl | 15 | $809 |
| Ofloxacin | 34 | $728 |
| Timolol Maleate | 57 | $679 |
| Latanoprost | 29 | $407 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Slingerlands
- Pawan BhatnagarSlingerlands$14K
- Spencer LangevinSlingerlands$2K
- Jamin BrownLiverpool$3.3M
- Brian ConnollyRochester$1.7M
- Paul HahnNanuet$1.1M
- Patrick OellersLiverpool$615K
- Edward HallRochester$264K
- Matthew WitmerRochester$246K
- Szilard KissNew York$222K
- Deepika MalikWoodbury$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.